Leader in Pharmacogenetics Appointed to National Advisory General Medical Sciences Council

Kathleen Giacomini

Kathleen M Giacomini, PhD, professor and chair of biopharmaceutical sciences, has been appointed to the National Advisory General Medical Sciences Council. The council is composed of leaders in the biological and medical sciences, education, health care and public affairs. Its members, who are appointed to four-year terms, perform peer review for research and research training grant applications in the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health (NIH). Council members also offer advice and recommendations on policy and program development, program implementation, evaluation and other matters of significance to the mission and goals of NIGMS. Giacomini was one of five new members appointed to the council last week by Health and Human Services Secretary Tommy Thompson. Giacomini, who is also professor of pharmaceutical chemistry and cellular and molecular pharmacology, is an expert on the transport of drug molecules into and out of cells. In the last five years she has been at the forefront of the new field of pharmacogenetics, researching how genetic variation can influence the way people respond to medicines. Photo by Christine Jegan

Related Links

NIH News Release Kathleen M Giacomini